About Contact Us Careers
Sign In

Microbial Fermentation Technology Market - Top Companies and Manufacturers

  • Report ID: 5329
  • Published Date: Oct 09, 2024
  • Report Format: PDF, PPT

Companies Dominating the Microbial Fermentation Technology Landscape

    • Biocon Ltd.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • BioVectra Inc.
    • Danone UK
    • F. Hoffmann-La Roche AG
    • Koninklijke DSM NV
    • Lonza
    • Novozymes A/S
    • TerraVia Holdings, Inc.
    • BIOZEEN
    • Royal DSM
Browse Key Market Insights with Data Illustration:

In the News

  • BioVectra Inc. announced to diversification of manufacturing Capacity with Single-Use Microbial Fermentation Technology to support even more potential biologics for technology transfer and optimization, and offer enhanced flexibility, faster turnaround times, and increased capacity utilization to the customers. Furthermore, single-use sterile fermenters are intended to offer mixing, oxygen transmission, and cooling and provide a unique option and a significant benefit over stainless-steel fermenters in terms of batch segregation and cross-contamination hazards.
  • Danone UK partnered with Chr Hansen to push for innovation in both dairy and plant-based products and supply its 1800 strains of ferments to further research on the gut microbiome to focus on customer health and improve sustainability by reducing greenhouse gas emissions in its supply chain

Author Credits:  Radhika Pawar


  • Report ID: 5329
  • Published Date: Oct 09, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of microbial fermentation technology is assessed at USD 36.57 billion.

The microbial fermentation technology market size was valued at USD 34.92 billion in 2024 and is set to reach USD 73.57 billion by the end of 2037, registering around 5.9% CAGR during the forecast period i.e., between 2025-2037. The rising need for vaccines and the growing need for microbial contract manufacturing services will drive the market growth.

Asia Pacific industry is set to dominate majority revenue share 42% by 2037, impelled by presence of the developed chemical sector in the region.

The major players in the market are BioVectra Inc., Danone UK, F. Hoffmann-La Roche AG, Koninklijke DSM NV, Lonza, Novozymes A/S, TerraVia Holdings, Inc., BIOZEEN
Inquiry Before Buying Request Free Sample

Copyright © 2024 Research Nester. All Rights Reserved

logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample